AU2002314149A1 - Ophthalmic compositions comprising hyaluronic acid - Google Patents

Ophthalmic compositions comprising hyaluronic acid

Info

Publication number: AU2002314149A1
Authority: AU; Australia
Prior art keywords: hyaluronic acid; ophthalmic compositions; ophthalmic; compositions; hyaluronic
Prior art date: 2001-06-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002314149A

Inventor

Maggy Babiole Saunier

Jean-Claude Bizec

Andrea Fetz

Christian Schoch

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis Pharma GmbH Austria

Original Assignee

Novartis Pharma GmbH Austria

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-08

Filing date

2002-06-07

Publication date

2002-12-23

2002-06-07 Application filed by Novartis Pharma GmbH Austria filed Critical Novartis Pharma GmbH Austria

2002-12-23 Publication of AU2002314149A1 publication Critical patent/AU2002314149A1/en

Status Abandoned legal-status Critical Current

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Virology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Furan Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2002314149A 2001-06-08 2002-06-07 Ophthalmic compositions comprising hyaluronic acid Abandoned AU2002314149A1 (en)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
EP01113958		2001-06-08
EP01113958.1		2001-06-08
EP01113959.9		2001-06-08
EP01113959		2001-06-08
EP01115096.8		2001-06-21
EP01115097		2001-06-21
EP01115097.6		2001-06-21
EP01115096		2001-06-21
PCT/EP2002/006279 WO2002100437A2 (en)	2001-06-08	2002-06-07	Ophthalmic compositions comprising hyaluronic acid

Publications (1)

Publication Number	Publication Date
AU2002314149A1 true AU2002314149A1 (en)	2002-12-23

Family

ID=27440131

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002314149A Abandoned AU2002314149A1 (en)	2001-06-08	2002-06-07	Ophthalmic compositions comprising hyaluronic acid

Country Status (9)

Country	Link
EP (1)	EP1404370A2 (en)
JP (1)	JP2005508866A (en)
CN (1)	CN1514735A (en)
AR (1)	AR034371A1 (en)
AU (1)	AU2002314149A1 (en)
BR (1)	BR0210139A (en)
CA (1)	CA2449213A1 (en)
PE (1)	PE20030206A1 (en)
WO (1)	WO2002100437A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002345015A1 (en) *	2001-06-08	2002-12-23	Novartis Pharma Gmbh	Ophthalmic once-a-day composition
US8580851B2 (en)	2002-08-21	2013-11-12	Sucampo Ag	Ophthalmic solution
JP2004143155A (en) *	2002-10-01	2004-05-20	Taisho Pharmaceut Co Ltd	Ophthalmic agent
US20040137079A1 (en) *	2003-01-08	2004-07-15	Cook James N.	Contact lens and eye drop rewetter compositions and methods
ES2431640T3 (en) *	2003-08-21	2013-11-27	Sucampo Ag	Ophthalmic composition comprising isopropyl ester of unoprostone and a viscosity agent
RU2336074C2 (en) *	2003-11-12	2008-10-20	Аллерган, Инк.	Compositions and methods of treatment of posterior ocular segment
US20050101582A1 (en) *	2003-11-12	2005-05-12	Allergan, Inc.	Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en)	2003-11-12	2007-09-27	Lyons Robert T	Low immunogenicity corticosteroid compositions
ATE418325T1 (en) *	2004-01-20	2009-01-15	Allergan Inc	COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, PREFERABLY CONTAINING TRIAMCINOLONE-ACETONIDE AND HYALURONIC ACID
US8119154B2 (en)	2004-04-30	2012-02-21	Allergan, Inc.	Sustained release intraocular implants and related methods
DE102005035986B4 (en) *	2005-07-28	2009-10-15	Bausch & Lomb Incorporated	Sterile drippable multiphase emulsifier-free ophthalmic preparation
US20070077302A1 (en) *	2005-09-30	2007-04-05	Azaam Alli	Methods for stabilizing ophthalmic compositions
CN100408046C (en) *	2005-12-22	2008-08-06	涂家生	Macrolide antibiotics sodium hyaluronate eye transfer system
US7767217B2 (en) *	2006-03-14	2010-08-03	Foresight Biotherapeutics	Ophthalmic compositions comprising povidone-iodine
US20090143348A1 (en) *	2007-11-30	2009-06-04	Ahmet Tezel	Polysaccharide gel compositions and methods for sustained delivery of drugs
RU2402315C2 (en) *	2009-01-21	2010-10-27	Федеральное государственное учреждение "МОСКОВСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ ИМЕНИ ГЕЛЬМГОЛЬЦА ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ВЫСОКОТЕХНОЛОГИЧНОЙ МЕДИЦИНСКОЙ ПОМОЩИ"	Reparative ophthalmic medicinal composition
WO2012047893A2 (en) *	2010-10-04	2012-04-12	Activbiotics Pharma, Llc	Use of rifazil and analogues thereof to treat ocular disorders
KR101412776B1 (en)	2013-03-11	2014-07-01	가톨릭대학교 산학협력단	Eye drop composition for treating keratoconjunctivitis and preparation method of the same
US10307408B2 (en)	2013-08-28	2019-06-04	Presbyopia Therapies, LLC	Contact lens compositions and methods for the treatment of presbyopia
US9320709B2 (en)	2013-08-28	2016-04-26	Presbyopia Therapies Llc	Storage stable compositions and methods for the treatment of refractive errors of the eye
US9314427B2 (en)	2013-08-28	2016-04-19	Presbyopia Therapies Llc	Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye
US9968594B2 (en)	2013-08-28	2018-05-15	Presbyopia Therapies Llc	Compositions and methods for the treatment of presbyopia
US10064818B2 (en)	2013-08-28	2018-09-04	Presbyopia Therapies, LLC	Compositions and methods for the treatment of presbyopia
US10617763B2 (en)	2013-08-28	2020-04-14	Presbyopia Therapies, LLC	Compositions and methods for the treatment of presbyopia
US9089562B2 (en) *	2013-08-28	2015-07-28	Presbyopia Therapies Llc	Compositions and methods for the treatment of presbyopia
US9844537B2 (en)	2013-08-28	2017-12-19	Presbyopia Therapies Llc	Compositions and methods for the treatment of presbyopia
US11179327B2 (en)	2013-08-28	2021-11-23	Lenz Therapeutics, Inc.	Compositions and methods for the treatment of presbyopia
US9833441B2 (en)	2013-08-28	2017-12-05	Presbyopia Therapies Llc	Compositions and methods for the treatment of presbyopia
ES2934790T3 (en)	2016-08-19	2023-02-27	Orasis Pharmaceuticals Ltd	Ophthalmic pharmaceutical compositions and uses related thereto
US20210251970A1 (en)	2018-10-10	2021-08-19	Presbyopia Therapies Inc	Compositions and methods for storage stable ophthalmic drugs
JP2023530188A (en) *	2020-06-21	2023-07-13	アイ．コムメディカルゲーエムベーハー	Use of high molecular weight hyaluronic acid as an ophthalmic drug delivery vehicle
EP4433053A4 (en)	2021-11-17	2025-09-17	Lenz Therapeutics Operations Inc	Aceclidine derivatives, compositions thereof and methods of using them
US11648247B1 (en)	2021-12-16	2023-05-16	Lenz Therapeutics, Inc.	Compositions and methods for the treatment of presbyopia
US12414942B1 (en)	2024-03-15	2025-09-16	Lenz Therapeutics Operations, Inc.	Compositions, methods, and systems for treating presbyopia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1229075B (en) *	1985-04-05	1991-07-17	Fidia Farmaceutici	Topical compsn. contg. hyaluronic acid deriv. as vehicle
RU2089191C1 (en) *	1994-01-28	1997-09-10	Научно-производственная фирма "Нарт"	Method of prolongation of physiological effect of thymolol with respect to intraocular pressure decreasing
CA2193149C (en) *	1995-12-22	2002-04-23	David H. Donabedian	Cationic therapuetic agents and delivery systems
JPH1160505A (en) *	1997-05-20	1999-03-02	Senju Pharmaceut Co Ltd	Antiseptic composition
DE19923829A1 (en) *	1999-05-17	2000-11-23	Ulrich Kluegel	Complex of hyaluronate, active ingredient and water, useful as topical pharmaceutical or cosmetic composition, is stable and has high content of active agent
US6777429B1 (en) *	1999-07-23	2004-08-17	Novartis Ag	Ophthalmic composition

2002
- 2002-06-06 AR ARP020102106A patent/AR034371A1/en unknown
- 2002-06-07 CA CA002449213A patent/CA2449213A1/en not_active Abandoned
- 2002-06-07 AU AU2002314149A patent/AU2002314149A1/en not_active Abandoned
- 2002-06-07 PE PE2002000483A patent/PE20030206A1/en not_active Application Discontinuation
- 2002-06-07 JP JP2003503256A patent/JP2005508866A/en active Pending
- 2002-06-07 BR BR0210139-4A patent/BR0210139A/en not_active Application Discontinuation
- 2002-06-07 EP EP02740697A patent/EP1404370A2/en not_active Withdrawn
- 2002-06-07 CN CNA028115317A patent/CN1514735A/en active Pending
- 2002-06-07 WO PCT/EP2002/006279 patent/WO2002100437A2/en not_active Ceased

Also Published As

Publication number	Publication date
CA2449213A1 (en)	2002-12-19
EP1404370A2 (en)	2004-04-07
BR0210139A (en)	2004-06-08
JP2005508866A (en)	2005-04-07
WO2002100437A3 (en)	2003-04-24
CN1514735A (en)	2004-07-21
WO2002100437A2 (en)	2002-12-19
AR034371A1 (en)	2004-02-18
PE20030206A1 (en)	2003-04-09

Publication	Publication Date	Title
AU2002314149A1 (en)	2002-12-23	Ophthalmic compositions comprising hyaluronic acid
AU1731101A (en)	2001-06-18	Ophthalmic compositions
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU2003235248A1 (en)	2003-10-27	Hyaluronic acid modification product
AU2002357086A1 (en)	2003-06-23	Healing abutment
AU2002365093A1 (en)	2003-07-09	Therapeutic compositions
AUPR600601A0 (en)	2001-07-26	Therapeutic compositions
AU2002360752A1 (en)	2003-07-30	Viscoelastics for ocular surgery
EP1438003B8 (en)	2008-10-08	Cosmetic compositions
AU2003249491A1 (en)	2004-02-23	Hyaluronic acid derivatives
AU2002345015A1 (en)	2002-12-23	Ophthalmic once-a-day composition
EP1366758A4 (en)	2005-07-20	Novel ophthalmic compositions
AU2002230229A1 (en)	2002-08-28	Novel ophthalmic compositions
AU2002346223A1 (en)	2003-05-15	Medicinal compositions
AU2001264002A1 (en)	2001-12-03	Acetazolamide-based ophthalmic solution
AU2002318815A1 (en)	2003-01-29	Medicinal compositions for opthalmic use
AU2002357696A1 (en)	2003-05-26	Chitosan compositions
AU2002317321A1 (en)	2003-01-29	Gel compositions
AUPR795301A0 (en)	2001-10-18	Novel compositions
AU2002313692A1 (en)	2003-03-03	Vision prosthesis
AU2002326822A1 (en)	2003-04-22	Pro-micelle pharmaceutical compositions
AU2002315611A1 (en)	2003-03-03	Fabric-cleaning compositions
AU2002320806A1 (en)	2003-07-10	Compositions
AUPR971001A0 (en)	2002-01-24	Compositions
AU2002302710A1 (en)	2002-11-25	Magnesium-enriched compositions

Legal Events

Date	Code	Title	Description
2004-03-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase